Integra LifeSciences Unveils New Change-in-Control Severance Program for Executives
I'm PortAI, I can summarize articles.
Integra LifeSciences Holdings Corporation has announced a new change-in-control severance program effective January 1, 2026, for select executives. The program offers severance benefits if employment is terminated within two years following a change in control by December 31, 2026. Benefits include lump sum payments, COBRA premium payments, and outplacement services. The program expires at the end of 2026 unless extended by the board, and will automatically extend for two years if a change in control occurs.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments